George Sekulich
President bei EMMAUS LIFE SCIENCES, INC.
Vermögen: 40 $ am 31.03.2024
Profil
George Sekulich is currently the Co-President, Director & Chief Commercial Officer at Emmaus Life Sciences, Inc. since 2023.
He is also currently the Chief Information Officer at EMI Holding, Inc. since 2014.
Previously, he worked as the Owner at Magellan Network Systems, Inc. Mr. Sekulich completed his undergraduate degree at California State University-Dominguez Hills.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2024 | 385 ( 0,00% ) | 40 $ | 31.03.2024 |
Aktive Positionen von George Sekulich
| Unternehmen | Position | Beginn |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | President | 23.08.2023 |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Chief Tech/Sci/R&D Officer | 01.09.2014 |
Ehemalige bekannte Positionen von George Sekulich
| Unternehmen | Position | Ende |
|---|---|---|
| Magellan Network Systems, Inc. | Corporate Officer/Principal | - |
Ausbildung von George Sekulich
| California State University-Dominguez Hills | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EMMAUS LIFE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
| Magellan Network Systems, Inc. |
